4
Registered trials
2
Recruiting
3
Completed trials
1
Countries active
6
Unique IMPs
100%
Results reported
100%
3 of 3 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).
Top indications
Top IMPs
ALLOGENEIC ADIPOSE-DERIVED ADULT MESENCHYMAL STEM CELLS EXPANDED
1
ALLOGENIC SCLEROCORNEAL LIMBUS STEM-DERIVED ADULT LIMBAL CELLS, EX-VIVO EXPANDED, ALLOGENIC CORNEAL-DERIVED ADULT KERATOCYTES, EX-VIVO EXPANDED
1
AMNIOTIC MEMBRANE, HUMAN
1
AUTOLOGOUS BONE MARROW-DERIVED ADULT MONONUCLEAR CELLS, NOT EXPANDED
1
AUTOLOGOUS SKIN-DERIVED ADULT KERATINOCYTES EXPANDED, AUTOLOGOUS SKIN-DERIVED ADULT FIBROBLASTS EXPANDED
1
SKIN AUTOGRAFT
1
All trials
4 totalShowing 1–4 of 4 trials